These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 27111215

  • 1. Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia.
    Charan A, Shewade DG, Rajkumar RP, Chandrasekaran A.
    Psychiatry Res; 2016 Jun 30; 240():209-213. PubMed ID: 27111215
    [Abstract] [Full Text] [Related]

  • 2. Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia.
    Alladi CG, RajKumar RP, Adithan S, Marie-Claire C, Bellivier F, Shewade DG.
    Fundam Clin Pharmacol; 2019 Jun 30; 33(3):355-364. PubMed ID: 30332506
    [Abstract] [Full Text] [Related]

  • 3. Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele.
    Young RM, Lawford BR, Barnes M, Burton SC, Ritchie T, Ward WK, Noble EP.
    Br J Psychiatry; 2004 Aug 30; 185():147-51. PubMed ID: 15286066
    [Abstract] [Full Text] [Related]

  • 4. The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.
    Roke Y, van Harten PN, Franke B, Galesloot TE, Boot AM, Buitelaar JK.
    Pharmacogenet Genomics; 2013 Sep 30; 23(9):487-93. PubMed ID: 23851570
    [Abstract] [Full Text] [Related]

  • 5. Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients.
    Yasui-Furukori N, Saito M, Tsuchimine S, Nakagami T, Sato Y, Sugawara N, Kaneko S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1491-5. PubMed ID: 18579277
    [Abstract] [Full Text] [Related]

  • 6. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.
    Calarge CA, Ellingrod VL, Acion L, Miller DD, Moline J, Tansey MJ, Schlechte JA.
    Pharmacogenet Genomics; 2009 May 01; 19(5):373-82. PubMed ID: 19339912
    [Abstract] [Full Text] [Related]

  • 7. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX, Su YA, Bian QT, Wei LH, Zhang RZ, Liu YH, Correll C, Soares JC, Yang FD, Wang SL, Zhang XY.
    Psychoneuroendocrinology; 2015 Aug 01; 58():130-40. PubMed ID: 25981348
    [Abstract] [Full Text] [Related]

  • 8. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.
    Kim KS, Pae CU, Chae JH, Bahk WM, Jun TY, Kim DJ, Dickson RA.
    J Clin Psychiatry; 2002 May 01; 63(5):408-13. PubMed ID: 12019665
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ, Gilmore JA, Liu H, Halbreich UM.
    Psychoneuroendocrinology; 2003 Apr 01; 28 Suppl 2():55-68. PubMed ID: 12650681
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.
    Mihara K, Kondo T, Suzuki A, Yasui N, Nagashima U, Ono S, Otani K, Kaneko S.
    Psychopharmacology (Berl); 2000 Apr 01; 149(3):246-50. PubMed ID: 10823405
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia.
    Iwata Y, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Plitman E, Chung JK, Mar W, Gerretsen P, Pollock BG, Mulsant BH, Rajji TK, Mamo DC, Graff-Guerrero A.
    J Clin Psychiatry; 2016 Dec 01; 77(12):e1557-e1563. PubMed ID: 28086010
    [Abstract] [Full Text] [Related]

  • 15. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R, Okumura M, Ito H, Takano A, Takahashi H, Takano H, Maeda J, Okubo Y, Suhara T.
    J Clin Psychiatry; 2010 Sep 01; 71(9):1131-7. PubMed ID: 20361897
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of smoking status on the plasma concentration of prolactin already elevated by risperidone treatment in schizophrenia patients.
    Ohta C, Yasui-Furukori N, Furukori H, Tsuchimine S, Saito M, Nakagami T, Yoshizawa K, Kaneko S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):573-6. PubMed ID: 21216266
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.